These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22422318)

  • 21. Local mobility in amorphous pharmaceuticals--characterization and implications on stability.
    Bhattacharya S; Suryanarayanan R
    J Pharm Sci; 2009 Sep; 98(9):2935-53. PubMed ID: 19499564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of water plasticization on the molecular mobility and crystallization tendency of amorphous disaccharides.
    Heljo VP; Nordberg A; Tenho M; Virtanen T; Jouppila K; Salonen J; Maunu SL; Juppo AM
    Pharm Res; 2012 Oct; 29(10):2684-97. PubMed ID: 22203327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
    Sun DD; Ju TC; Lee PI
    Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of amorphous itraconazole stabilization in polymer solid dispersions: role of molecular mobility.
    Bhardwaj SP; Arora KK; Kwong E; Templeton A; Clas SD; Suryanarayanan R
    Mol Pharm; 2014 Nov; 11(11):4228-37. PubMed ID: 25325389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Controlled Relative Humidity Storage on Moisture Sorption and Amylopectin Retrogradation in Gelatinized Starch Lyophiles.
    Johnson KA; Mauer LJ
    J Food Sci; 2019 Mar; 84(3):507-523. PubMed ID: 30779350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Applicability of the one-step DVS method for the determination of amorphous amounts for further different hydrophilic and hydrophobic drugs.
    Müller T; Scherließ R; Schiewe J; Smal R; Weiler C; Steckel H
    Eur J Pharm Biopharm; 2015 Aug; 94():333-41. PubMed ID: 26079523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of Glass Forming Ability on the Physical Stability of Supersaturated Amorphous Solid Dispersions.
    Blaabjerg LI; Bulduk B; Lindenberg E; Löbmann K; Rades T; Grohganz H
    J Pharm Sci; 2019 Aug; 108(8):2561-2569. PubMed ID: 30878513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of temperature on water vapor sorption by some amorphous pharmaceutical sugars.
    Hancock BC; Dalton CR
    Pharm Dev Technol; 1999 Jan; 4(1):125-31. PubMed ID: 10027221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques.
    van Drooge DJ; Hinrichs WL; Visser MR; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):220-9. PubMed ID: 16427226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isothermal microcalorimetry to investigate the phase separation for amorphous solid dispersions of AMG 517 with HPMC-AS.
    Calahan JL; Zanon RL; Alvarez-Nunez F; Munson EJ
    Mol Pharm; 2013 May; 10(5):1949-57. PubMed ID: 23574401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystallization rate of amorphous nifedipine analogues unrelated to the glass transition temperature.
    Miyazaki T; Yoshioka S; Aso Y; Kawanishi T
    Int J Pharm; 2007 May; 336(1):191-5. PubMed ID: 17184940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymer combination increased both physical stability and oral absorption of solid dispersions containing a low glass transition temperature drug: physicochemical characterization and in vivo study.
    Sakurai A; Sakai T; Sako K; Maitani Y
    Chem Pharm Bull (Tokyo); 2012; 60(4):459-64. PubMed ID: 22466729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Near-infrared imaging for high-throughput screening of moisture induced changes in freeze-dried formulations.
    Trnka H; Palou A; Panouillot PE; Kauppinen A; Toiviainen M; Grohganz H; Alcalà M; Juuti M; Ketolainen J; Rantanen J
    J Pharm Sci; 2014 Sep; 103(9):2839-2846. PubMed ID: 24665039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Moisture-dependent crystallization of amorphous lamotrigine mesylate.
    Schmitt E; Davis CW; Long ST
    J Pharm Sci; 1996 Nov; 85(11):1215-9. PubMed ID: 8923328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase behavior of amorphous molecular dispersions I: Determination of the degree and mechanism of solid solubility.
    Vasanthavada M; Tong WQ; Joshi Y; Kislalioglu MS
    Pharm Res; 2004 Sep; 21(9):1598-606. PubMed ID: 15497685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of aging on the physical properties of amorphous trehalose.
    Surana R; Pyne A; Suryanarayanan R
    Pharm Res; 2004 May; 21(5):867-74. PubMed ID: 15180347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Temperature and Moisture on the Physical Stability of Binary and Ternary Amorphous Solid Dispersions of Celecoxib.
    Xie T; Taylor LS
    J Pharm Sci; 2017 Jan; 106(1):100-110. PubMed ID: 27476771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Examination of Water Vapor Sorption by Multicomponent Crystalline and Amorphous Solids and Its Effects on Their Solid-State Properties.
    Newman A; Zografi G
    J Pharm Sci; 2019 Mar; 108(3):1061-1080. PubMed ID: 30391302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glass transition and time-dependent crystallization behavior of dehydration bioprotectant sugars.
    Schebor C; Mazzobre MF; Buera Mdel P
    Carbohydr Res; 2010 Jan; 345(2):303-8. PubMed ID: 19962131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.